NRF2 controls a diverse network of antiviral effectors with p62 acting as a central restriction factor effective across virus families

This publication has 61 references indexed in Scilit:

• The HIF transcription network exerts innate antiviral activity in neurons and limits brain inflammation
  Cell Reports, 2024
• Nrf2 activation reprograms macrophage intermediary metabolism and suppresses the type I interferon response
  iScience, 2022
• Influenza A induces lactate formation to inhibit type I IFN in primary human airway epithelium
  iScience, 2021
• Constitutive and latent immune mechanisms exert ‘silent’ control of virus infections in the central nervous system
  Current Opinion in Immunology, 2021
• SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
  Cell, 2020
• RA-839, a selective agonist of Nrf2/ARE pathway, exerts potent anti-rotaviral efficacy in vitro
  Antiviral Research, 2019
• Interferon-stimulated genes and their antiviral effector functions
  Current Opinion in Virology, 2011
• Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosis
  Biochemical Pharmacology, 2008
• Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide
  Biochemical and Biophysical Research Communications, 2006
• An Nrf2/Small Maf Heterodimer Mediates the Induction of Phase II Detoxifying Enzyme Genes through Antioxidant Response Elements
  Biochemical and Biophysical Research Communications, 1997